PubMed Health⌕ Search

PubMed · 6766624

Flow-controlled therapeutic embolization: a physiologic and safe technique.

Abstract

A feared complication of therapeutic embolization is loss of control of one or more particles with resultant ischemic infarction of normal tissues. To avoid passage of emboli into normal arteries, the delivery catheter may be wedged tightly into the artery or the artery completely occluded with a balloon catheter during embolus injection. These techniques, termed occlusion control, were a valuable forward step and significantly enhanced patient safety. However, occluding the vessel completely may cause spasm, and allows the operator to introduce fluid and emboli under higher than normal perfusion pressures which can open extra- to intracranial shunts and cause disastrous intracranial embolization. A further refinement is suggested. First, the emboli are suspended in contrast agent; then the particles are introduced while arterial runoff of the contrast agent is watched so the acceptance rate of the artery is not exceeded. Normal perfusion pressures and flow then carry the embolus distally into the abnormality being treated. This technique is safe, easily learned, and gives the radiologist direct vision control over the embolization process. It has been used in39 patients with only one serious complication.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C W Kerber. 1980. Flow-controlled therapeutic embolization: a physiologic and safe technique.. https://doi.org/10.2214/ajr.134.3.557

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Immune heparin-induced thrombocytopenia resulting from preceding exposure to heparin catheter flushes.

Immune heparin-induced thrombocytopenia (HIT) is a life-threatening adverse effect of heparin. It can result from any type of heparin exposure and by any route of administration; however only a few cases are reported after exposures to small quantities of heparin from catheter flushes. The major clinical problem associated with HIT is thrombosis. Early detection and institution of alternative, non-heparin anticoagulation are important. We report a patient with HIT associated with use of therapeutic-dose unfractionated heparin in whom immune sensitization to heparin was triggered by two 500-unit exposure to UFH associated with intravascular catheter flushing for antineoplastic chemotherapy in a patient with colon adenocarcinoma.

Catheterization↗